Study to Investigate Safety and Tolerability of mRNA-0184 Administered Under Different Infusion Conditions in Healthy Participants

A Randomized, Double-Blind, Placebo-Controlled, Clinical Trial to Evaluate the Safety, Tolerability, Efficacy, and Pharmacodynamics for the Treatment of COVID-19.

NCT04847544 ·Status: COMPLETED ·Phase: PHASE2

CC-42344 Safety Study in Healthy Participants

NCT05202379 ·Status: COMPLETED ·Phase: PHASE1

Safety and Tolerability Study of IV ST266 in COVID-19 Subjects

NCT04720378 ·Status: COMPLETED ·Phase: PHASE1

Efficacy and Safety of Molnupiravir (MK-4482) in Hospitalized Adult Participants With COVID-19 (MK-4482-001)

NCT04575584 ·Status: TERMINATED ·Phase: PHASE2/PHASE3

Intravenous Infusion of CAP-1002 in Patients With COVID-19

NCT04623671 ·Status: COMPLETED ·Phase: PHASE2

A Study on the Effects in Healthy People of a New Drug Called PDI204 for Treating COVID-19

NCT06965751 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

A Study to Assess Safety, Tolerability, and Immunogenicity of V591 (COVID-19 Vaccine) in Healthy Participants (V591-001)

NCT04498247 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

Safety and Immunogenicity of the Candidate Vaccine MVA-SARS-2-S and a Booster Vaccination With a Licensed Vaccine Against COVID-19

NCT04569383 ·Status: COMPLETED ·Phase: PHASE1

Evaluation of Full Versus Fractional Doses of COVID-19 Vaccines Given as a Booster in Adults in Australia - Mongolia, Indonesia, Australia Coronavirus (MIACoV).

NCT05228730 ·Status: TERMINATED ·Phase: PHASE3

Study of VIR-2482 in Healthy Volunteers

NCT04033406 ·Status: COMPLETED ·Phase: PHASE1

Efficacy and Safety of Molnupiravir (MK-4482) in Non-Hospitalized Adult Participants With COVID-19 (MK-4482-002)

NCT04575597 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Intradermal Administration of a COVID-19 mRNA Vaccine in Elderly

NCT05977127 ·Status: TERMINATED ·Phase: PHASE2

SCB-2019 as COVID-19 Vaccine

NCT04405908 ·Status: COMPLETED ·Phase: PHASE1

Safety and Efficacy of Intranasal Administration of Avacc 10 Vaccine Against COVID-19 in Healthy Volunteers

NCT05604690 ·Status: COMPLETED ·Phase: PHASE1

Study of Recombinant Protein Vaccine Formulations Against COVID-19 in Healthy Adults 18 Years of Age and Older

NCT04537208 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Real-world Evidence Study of BNT162b2 mRNA Covid-19 Vaccine in Brazil

NCT05052307 ·Status: COMPLETED

Efficacy,Immunogenicity and Safety of COVID-19 Vaccine , Inactivated Booster Dose in Adults Aged 18 Years and Above

NCT05156632 ·Status: WITHDRAWN ·Phase: PHASE3

First-In-Human Study To Evaluate Safety, Tolerability, And Pharmacokinetics Following Single Ascending And Multiple Ascending Doses of PF-07304814 In Hospitalized Participants With COVID-19.

NCT04535167 ·Status: COMPLETED ·Phase: PHASE1

A Ph 2 Trial With an Oral Tableted COVID-19 Vaccine

NCT05067933 ·Status: TERMINATED ·Phase: PHASE2

Safety and Immunogenicity Study of Inactivated Vaccine for Prevention of SARS-CoV-2 Infection(COVID-19)

NCT04383574 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)

NCT06667700 ·Status: RECRUITING ·Phase: PHASE3

Fourth Dose of mRNA COVID-19 Vaccine in Residents of LTCFs

NCT04978038 ·Status: UNKNOWN ·Phase: PHASE4

COVID-19: A Trial Studying the SARS-CoV-2 mRNA Vaccine CVnCoV to Learn About the Immune Response, the Safety, and the Degree of Typical Vaccination Reactions When CVnCoV is Given at the Same Time as a Flu Vaccine Compared to When the Vaccines Are Separately Given in Adults 60 Years of Age and Older

NCT04848467 ·Status: WITHDRAWN ·Phase: PHASE3

Clinical Trial of COVID-19 Vaccine（SARS-CoV-2 Variant(Omicron BA.5) mRNA Vaccine） in Participants Aged 18 Years and Over

NCT05745545 ·Status: UNKNOWN ·Phase: NA

Therapeutic Vaccine Trial of COVID-19 for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection

NCT04428073 ·Status: UNKNOWN ·Phase: PHASE1